<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

• Main Authors: Ricardo D. Gonzalez (Author), George W. Small (Author), Adrian J. Green (Author), Farida S. Akhtari (Author), Alison A. Motsinger-Reif (Author), Julia C. F. Quintanilha (Author), Tammy M. Havener (Author), David M. Reif (Author), Howard L. McLeod (Author), Tim Wiltshire (Author)
• Format: Book
• Published: MDPI AG, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oxaliplatin (OXAL) is a commonly used chemotherapy for treating colorectal cancer (CRC). A recent genome wide association study (GWAS) showed that a genetic variant (rs11006706) in the lncRNA gene <i>MKX-AS1</i> and partnered sense gene <i>MKX</i> could impact the response of...